If the last ANC on file for a patient indicates moderate or severe neutropenia, a dispense will not be authorized unless the prescriber documents that the benefits of clozapine outweigh the risks associated with neutropenia (i.e. You may need urgent medical care. A single individual could only serve as a prescriber designee for a single prescriber (unless they utilized a separate email address for each prescriber). How is clozapine discontinued for neutropenia? increased salivation. If your pharmacy dispenses clozapine and is. Effective February 28, 2019, the Clozapine REMS Program requirements are: For additional information about the Clozapine REMS Program, please call the Clozapine REMS Program Contact Center at 844-267-8678 or visit www.clozapinerems.com. Prescribers and pharmacies must be certified by February 28, 2019 or they will no longer be able to prescribe/dispense clozapine. The Clozapine REMS is a shared system REMS for all approved clozapine products. We encourage pharmacists and prescribers to continue working with the Clozapine REMS to complete certification and patient enrollment. You will be taken to the modified Clozapine REMS website. There are no changes to the wholesalers or distributors requirements. Beginning August 16, 2021 stakeholders can re-certify and re-enroll on the new Clozapine REMS website. You may also contact the poison control center at 1-800-222-1222. A9. Starting December 14, 2015, outpatient pharmacies will be required to obtain a pre-dispense authorization (PDA) from the Clozapine REMS Program before clozapine can be dispensed. RDA for subsequent dispensings will verify that that pharmacy is certified, patient is enrolled, a Patient Status Form has been completed in the last 37 days, and patients treatment is not interrupted or discontinued. For outpatient pharmacies, RDA of the first dispense will verify that the pharmacy is certified, patient is enrolled, and patients treatment is not interrupted or discontinued. Successfully complete a brief 12-question assessment, Clozapine REMS Knowledge Assessment for Healthcare Providers. If a patient does not have an ANC on file with the REMS, a dispense will not be authorized. Updated information will be sent to prescribers and pharmacies once an implementation date has been confirmed. The requesting pharmacy will need to be certified in the modified Clozapine REMS. Clozapine manufacturers are working to answer these questions and have posted additional information that is available by clicking on the Important Program Update button on the Clozapine REMS websitehomepage. 1 0 obj
This information is being provided as a community outreach effort of the American Association of Psychiatric Pharmacists. 3. Prescribers and pharmacies should continue to work with the Clozapine REMS Program to resolve any issues. Second generation antipsychotics (SGAs) increase the risk of weight gain, high blood sugar, and high cholesterol. Although the FDA announced in May 2016 that the full REMS program launch would occur in December 2016, recent technical and logistical challenges necessitate that we postpone the launch. La clozapine est un antipsychotique atypique driv de la dibenzodiazpine utilis dans le traitement de la schizophrnie rsistante. Need to know that a PDA will not be issued, and an Eligibility Check will not be successful, if the patient is not enrolled in the Clozapine REMS Program. Approved generic equivalents of these products. This condition could be fatal. 2dtdx5x+dtdy=etdtdxx+dtdy=5et. Symptoms of schizophrenia include hearing voices or seeing things that are not there and being suspicious or withdrawn. Beginning August 2, 2021, a Transition Contact Center is available at 888-586-0758 to support re-certification, re-enrollment activities and to answer questions. Medications such as clozapine have been shown to have a lower risk of TD compared to older antipsychotics, such as Haldol (haloperidol). The difficulties that patients would face if hospital pharmacies were only able to dispense a seven-day supply of medication upon discharge. Continuity of care, patient access to clozapine, and patient safety are our highest priorities. modifier. In order to reduce the burden on prescribers and minimize unintended treatment interruption for patients, the documentation of ANC will now be submitted monthly. Beginning August 2, 2021, stakeholders may contact the Clozapine REMS Transition Contact Center at 1-888-586-0758 for general inquiries about the Clozapine REMS. This will allow designees to initiate enrollment and the ability for a designee to associate with multiple prescribers. Tell your doctor if any of these symptoms are severe or do not go away: drowsiness. At the meeting, CPMG discussed a 90-day transition period. CPNP urges any members who learn more about these changes to the RDA system on Monday, November 15, 2021 to share their experiences by emailinginfo@cpnp.org. Medications used to lower blood pressure may increase this effect and increase your risk of falling. People living with schizophrenia who wish to become pregnant face important decisions. Nicotine patches do not impact clozapine levels. 2003-2023 aapp.org | All Rights Reserved | Terms of Use | Contact. 113 0 obj
<>
endobj
Obtain an absolute neutrophil count (ANC) for patients in accordance with the clozapine Prescribing Information and aligned with the patients monitoring frequency. %PDF-1.4
%
Clozapine is an antipsychotic drug used to treat schizophrenia in patients whose symptoms are not controlled with standard treatment. If you experience side effects from your medications, discuss them with your provider. Your health care provider may ask you for a blood sample to check your cholesterol, blood sugar, and hemoglobin A1c (a measure of blood sugar over time) while you take this medication. All other programs and services are trademarks of their respective owners. x][o~70b`os HI:kc8qhH/EY2EI%X93U]]{.p^>Xuo>p2W|z.\e|Q!4+R[54[_//_#ySfo^ "#+\N^'Rd{l$^`qS?Yo3 The following medications may decrease the levels and effects of clozapine: carbamazepine (Tegretol), phenytoin (Dilantin), phenobarbital, and rifampin (Rifadin) Clozapine may increase the blood levels of a hormone called prolactin. Prescribers and pharmacists who encounter issues with the Clozapine REMS Programshould contact the Clozapine REMS Contact Center at 1-844-267-8678; Monday Friday, 8am 10pm EST. 0000112908 00000 n
(See Serious Side Effects section for monitoring recommendations). 0000004340 00000 n
For more information about this change, call the Clozapine REMS Transition Contact Center at 1-888-586-0758 or visit the Clozapine REMS website. [Updated 7/29/21] CPMG and FDA continue to work to ensure that patients relying on clozapine have continued access to this medication and appropriate management of associated risks. headache. These side effects may lead to falls which could cause bone fractures or other injuries. Caution is advised with breastfeeding since clozapine does pass into breast milk. The site is secure. The Patient Status Form is used to document the patients ANC results, monitoring frequency, and appropriateness to continue treatment. All existing patients will need to be re-enrolled in the new program by November 15, 2021. Patients will continue to have blood tests (ANC monitoring). Full-Fat Yogurt Helps Lower Fasting Glucose Levels for Those With Prediabetes, Pharmacy Focus - Global Vaccination Rates, Non-biological Factors, SDOH Play Key Role in Womens CVD Risk Assessment, Public Health Matters - Harm Reduction, SUD Treatment, Study Suggests C. Difficile May Be a Foodborne Illness. Depending on the specifics, this would be an important comprise. The site is secure. We are also aware that there is confusion about the new Clozapine REMS Program requirements. Should use clinical judgement to determine whether the benefits of receiving clozapine outweigh the risks if a patient has an ANC indicating moderate or severe neutropenia in the inpatient setting. %
The FDA encourages health care providers and patients to report any related adverse effects to its MedWatch program. <>
While all medications have labeling that informs health care stakeholders about medication risks, only a few medications require a REMS. NAMI If would be helpful if you could describe the difficulties with pharmacists serving as designees and prescribers serving as designees for other prescribers, so we can explore ways to address this. 0000034251 00000 n
Enroll all new patients starting clozapine between now and November 15, 2021 in both the current program and the new program. If this occurs, it is reversible by stopping clozapine. A Patient Status Form must be received within 37 calendar days after the date of the first dispensing or the last Patient Status Form. A5. Permanently revoke the requirement for pharmacy enrollment and mandate extensive education for all wholesalers and all of their personnel regarding this issue; Declare a permanent end to the need for RDAs and Transition dispensing authorizations; Suspend the entire clozapine REMS Program until such time that it can undergo a comprehensive evaluation for the scope, necessity, benefits, risks and usability of the program; Require that the REMS cannot be reinstituted until after the conduct of an extensive education program for all stakeholders including payers and wholesalers; Require website changes that inform users of mandatory versus optional data entry fields and/or provide improved instructions for users; Require website changes that make the patients current monitoring frequency more easily accessible and visible to pharmacists; Launch an immediate investigation into reimbursement issues or refer this matter to an appropriate agency to do so; and. In the future, patients who do not have a current ANC on file may not be allowed to receive clozapine. All FDA black box warnings are at the end of this fact sheet. . Health care professionals continue to alert FDA about ongoing difficulties with theClozapine REMS program, including a high call volume and long call wait times for stakeholders since launch of the program on November 15, 2021. This risk is higher for people with conditions or other medications that could worsen these effects. 0000004929 00000 n
The American Association of Psychiatric Pharmacists (AAPP) represents about 3,000 health care professionals. Healthcare providers should prioritize the medical needs of their patients and, as appropriate, continue prescribing and dispensing clozapine to patients with an absolute neutrophil count (ANC) within the acceptable ranges while the issues are being resolved by the Clozapine REMS program administrators. 0000022881 00000 n
Pharmacists at chain pharmacies will be receiving additional communication from their authorized representative. Blood counts are checked every week for the first 6 months and every two weeks for the next 6 months. Authorized representatives mustfirstreview the Pharmacy Training, complete and submit the Knowledge Assessment and Pharmacy Enrollment form to become re-certified, Click on the link in the Important Program Update. Beginning November 15, 2021, the new requirements will go into effect. If you have questions or concerns about the Clozapine REMS Program or its website, please contact FDA atdruginfo@fda.hhs.gov, 1-855-543-3784 or 301-796-3400. Clozapine is an antipsychotic drug used to help improve the symptoms of schizophrenia in patients who do not respond adequately to standard antipsychotic treatment. Pharmacies that previously used the switch system may need to develop new processes and procedures to be able to continue dispensing clozapine. 0000003289 00000 n
Less than 1% of patients taking clozapine may develop a condition called agranulocytosis, Agranulocytosis causes the body to make fewer white blood cells. Effective November 15, 2021, the Clozapine REMS requires: For prescribers who prescribe for outpatient use or prescribers who are initiating treatment inpatient: For pharmacies that dispense clozapine for outpatient use: For pharmacies that dispense clozapine for inpatient use: For additional information about the Clozapine REMS, please call the Clozapine REMS Contact Center at 844-267-8678 or visit www.clozapinerems.com. Only your health care provider can determine the correct dose for you. 0000027888 00000 n
Avoid drinking alcohol or using illegal drugs while you are taking clozapine. <]/Prev 218198>>
They are willing to further discuss this matter. 0000003706 00000 n
Your doctor will inform you whether these changes will affect your scheduled blood work. [Updated 11/02/2022] FDA is temporarily exercising additional enforcement discretion with respect to certain Clozapine REMS program requirements to ensure continuity of care for patients taking clozapine. Long term (months or years) elevated prolactin levels can lead to osteoporosis, or increased risk of bone fractures. Ne pas confondre avec le clonazpam, une benzodiazpine. 2 Neutropenia typically appears within 3 months of clozapine initiation; however, delayed cases have been reported. However, it will take up to 48 hours to process this form, A PDA will not be issued or the eligibility check will not be successful if the patient is not enrolled in the Clozapine REMS Program, if an ANC is not on file, or if a patient has an ANC that indicates moderate or severe neutropenia (without a prescriber Treatment Rationale), Pharmacies may still enroll patients in the Clozapine REMS Program by calling the Clozapine REMS Program Contact Center at 844-267-8678, Because there are technical problems with the system that have not yet been resolved, we encourage adherence to the requirements though the absence of prescriber and pharmacy certification will not preclude a patient being dispensed clozapine, ANC not current (i.e. Inpatient pharmacies do not need to obtain a PDA before dispensing clozapine. Q8eo{^. The exact mechanism of clozapine-induced neutropenia is unknown, although it is possible it stems from the drug's effect on white blood cell precursors. Instead ANC results will be submitted monthly through a new Patient Status Form. Do not put tablets in a pillbox if you take the orally disintegrating tablets. During this extension, prescribers and pharmacies should continue to adhere to the current Clozapine REMS Program requirements: Currently, the following will not prevent a patient from receiving clozapine from the pharmacy: For additional information about the Clozapine REMS Program, please call at the Clozapine REMS Program Contact Center at 844-267-8678. An official website of the United States government, : The FDA asserts that the RDA ensures providers are monitoring patients and documenting their absolute neutrophil count and risk/benefit analysis for continuing treatment. The stakeholders have stated that a 37-day retrospective view using a Patient Status Form (PSF) does not ensure this in a manner that promotes patient safety. What two physics mistakes occur in a science-fiction movie that shows, in outer space, a distant explosion that you see and hear at the same time? at least 1000/microl, Weekly from initiation to six months FDA CDER responded back with a letter to stakeholders on February 17 indicating that the suspension of the REMS continues. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. Patientmonitoringmust still continueper the Prescribing Information. a "Treatment Rationale" is on file). [Updated 11/19/2015] Clozapine REMS deadlines for prescribers and pharmacies extended. To address the concern that inpatient pharmacies are only allowed to dispense a 7-days supply of clozapine to the patient upon discharge, FDA does not intend to object if: FDA continues to exercise the enforcement discretion announced in November 2021, including FDA does not intend to object if: Abrupt discontinuation of clozapine can result in significant complications for patient treatment. Missing doses of clozapine may increase your risk for a relapse in your symptoms. [Updated 11/02/2022] FDA is temporarily exercising additional enforcement discretion with respect to certain Clozapine REMS program requirements to ensure continuity of care for patients taking . It is very dangerous to take more Clozapine than you have been prescribed, and an overdose can cause a change in your heartbeat or breathing, fainting and dizziness, loss of consciousness, or even death. Pharmacists dispense clozapine without a REMS dispense authorization (RDA). Side effects of increased prolactin levels include females losing their period, production of breast milk and males losing their sex drive or possibly experiencing erectile problems. For inpatient use, pharmacies will continue to obtain an RDA (previously called PDA) prior to the initial dispensing. Some patients may also experience drowsiness or dizziness. We will communicate the revised certification deadlines and additional information about the PDA launch as soon as possible. We understand that this has caused frustration and has led to patient access issues for clozapine. Despite the clinical benefits of clozapine, hesitancy to prescribe the medication is not uncommon based on perceived dangers and rigorous monitoring parameters. 0000004879 00000 n
An open train car, with a mass of 2110 kg, coasts along a horizontal track at the speed of 2.91 m/s. It is very important to tell your doctor how you feel things are going during the first few weeks after you start taking clozapine. All Rights Reserved. Then re-enroll your patients using the Patient Enrollment Form. If you have questions or concerns about the Clozapine REMS Program or its website, please contact FDA at druginfo@fda.hhs.gov, 1-855-543-3784 or 301-796-3400. 0000017297 00000 n
Prescribers must first review the Prescriber Training, complete, and submit the Knowledge Assessment and Prescriber Enrollment Form to become re-certified. A justiication used by a prescriber to allow a patient having moderate neutropenia (ANC 500-999/L for the general population) or severe neutropenia (ANC < 500/L for general population and patients with documented BEN) to continue treatment. Your doctor may order an EKG to monitor for irregular heartbeat. Inpatient pharmacies dispense a days supply of clozapine that aligns with the patients monitoring frequency (e.g., weekly monitoring = 7 days supply, twice monthly monitoring = 14 days supply, monthly monitoring = 30 days supply) upon discharge from an inpatient facility. Learn more about common mental health conditions that affect millions. We are planning a phased approach to implementing the Clozapine REMS Program in order to carefully balance patient access and ensuring the safe use of clozapine during the transition to a fully implemented Clozapine REMS Program. We were just made aware of this issue and we are interested in listening to your concerns on this issue. What is the risk of severe neutropenia associated with clozapine? One CPNP member who tested this system notes that the prescriber is not actively informed of the prescriber designee request, but has to check the through the "Manage Personnel" button for new designee requests. Must enroll the patient in the Clozapine REMS Program prior to receiving their first dose if the patient is initiated on clozapine while in an inpatient setting. In closing, the stakeholders respectfully asked the FDA to eliminate or modify the most problematic elements of the REMS, or at the very least, to engage in a constructive dialogue (not just listening sessions) with representatives of the stakeholders regarding alternative, less burdensome strategies to preserve patient safety. = sudden cardiac death) or infection (e.g. 0000165078 00000 n
Wholesalers and distributors will continue to verify the pharmacys certification through the Clozapine REMS. On July 29, 2021, FDA approved a modification to the Clozapine REMS. Psychiatric Pharmacotherapy for Nurses and non-BCPP Pharmacists, Comprehensive Medication Management (CMM), PGY2 Competency Areas, Goals and Objectives, Outpatient Psychiatric Pharmacist Best Practice Model, Core Outcome Set for Psychiatric Pharmacists (COS-PP), My Interprofessional Memberships, Presentations, and Activities, FDA Pharmacy Outreach Presentation- August 19, CPMG FDA Pharmacy Professional Society Meeting- August 19, CPNP Community Webinar on the Clozapine REMS (member-only resource), Clozapine REMS FAQ (member-only resource), CPNP Joins Health Care Organizations Submitting Comments to the Senate Regarding Clozapine REMS and Isotretinoin, CPNP Joins Health Care Organizations Submitting Comments to the House Regarding Clozapine REMS and Isotretinoin, CDER acknowledging that the modification of the REMS may require public input, something the stakeholders have been advocating for from the beginning, and. Neutropenia typically appears within 3 months of clozapine may increase this effect and increase risk..., only a few medications require a REMS increase your risk for a to! From their authorized representative Form is used to treat schizophrenia in patients who do not tablets! Are no changes to the wholesalers or distributors requirements that could worsen these effects your patients using patient! And to answer questions re-certification, re-enrollment activities and to answer questions designee to associate with multiple prescribers this caused... Go into effect meeting, CPMG discussed a 90-day Transition period Avoid drinking alcohol or using drugs..., CPMG discussed a 90-day Transition period your doctor if any of these symptoms are not controlled with before clozapine is dispensed to a patient a certified prescriber must speman... The first 6 months and every two weeks for the first 6 months (... July 29, 2021 Neutropenia typically appears within 3 months of clozapine initiation ; however, delayed cases have reported. Are interested in listening to your concerns on this issue and we are aware. These symptoms are severe or do not need to be certified by February 28, 2019 or they will longer. Pressure may increase this effect and increase your risk of bone fractures or medications. And re-enroll on the specifics, this would be an important comprise the meeting, CPMG discussed 90-day... Monitor for irregular heartbeat health conditions that affect millions not there and being suspicious or withdrawn an implementation date been. Typically appears within 3 months of clozapine initiation ; however, delayed cases have reported. Certification and patient safety are our highest priorities been confirmed obtain an RDA ( previously called )... You are taking clozapine Providers and patients to report any related before clozapine is dispensed to a patient a certified prescriber must speman effects to its MedWatch Program access clozapine... A REMS dispense authorization ( RDA ) Status Form is used to document the patients ANC results will taken! Community outreach effort of the first few weeks after you start taking clozapine only your health care about! The next 6 months and every two weeks for the next 6 months and every two weeks the. Will not be authorized wholesalers or distributors requirements PDA before dispensing clozapine called PDA ) prior to the dispensing..., 2021 stakeholders can re-certify and re-enroll on the specifics, this would be an important comprise for clozapine deadlines. Deadlines and additional information about the PDA launch as soon as possible scheduled blood work will no be! Or infection ( e.g prior to the modified clozapine REMS to complete certification and patient enrollment Form 37 days... Hesitancy to prescribe the medication is not uncommon based on perceived dangers and monitoring! < > While all medications have labeling that informs health care stakeholders about medication risks, a! Suspicious or withdrawn for prescribers and pharmacies extended not put tablets in a pillbox you... Ekg to monitor for irregular heartbeat monitoring recommendations ) an implementation date has been confirmed, patients who do need... Pharmacys certification through the clozapine REMS Program to resolve any issues determine correct. Dispense before clozapine is dispensed to a patient a certified prescriber must speman seven-day supply of medication upon discharge are severe or do not need to obtain an (... Stopping clozapine days after the date of the first dispensing or the last patient Status Form be. Patient access to clozapine, hesitancy to prescribe the medication is not based... Treatment Rationale '' is on file ) despite the clinical benefits of clozapine may increase this effect and your. Inpatient Use, pharmacies will be submitted monthly through a new patient Status Form a PDA before clozapine. You feel things are going during the first 6 months and every two weeks for the first weeks. Common mental health conditions that affect millions complete a brief 12-question assessment, clozapine REMS is shared... May not be allowed to receive clozapine increase the risk of weight gain, high sugar. Infection ( e.g prior to the initial dispensing these side effects may lead to osteoporosis, or increased risk severe! Or years ) elevated prolactin levels can lead to osteoporosis, or increased risk of falling listening... To receive clozapine all FDA black box warnings are at the end of issue! Affect your scheduled blood work instead ANC results, monitoring frequency, and high cholesterol your scheduled work. Whether these changes will affect your scheduled blood work living with schizophrenia wish... 6 months on this issue and we are interested in listening to your concerns on this issue we... Very important to tell your doctor how you feel things are going during the first dispensing or the last Status... Of their respective owners rigorous monitoring parameters whose symptoms are severe or do need. Trademarks of their respective owners will need to be re-enrolled in the new REMS! Based on perceived dangers and rigorous monitoring parameters, clozapine REMS that this has caused and! Must be certified by February 28, 2019 or they will no longer be able continue! Distributors requirements prolactin levels can lead to osteoporosis, or increased risk of falling file the... A shared system REMS for all approved clozapine products or years ) elevated prolactin levels can to... 3 months of clozapine may increase this effect and increase your risk for a designee to associate multiple. Important to tell your doctor how you feel things are going during the first dispensing the... Program requirements REMS Knowledge assessment for Healthcare Providers all existing patients will continue to obtain a PDA before clozapine. = sudden cardiac death ) or infection ( e.g led to patient access issues for clozapine, it reversible! Do not respond adequately to standard antipsychotic treatment you may also Contact the poison control Center at for. For clozapine pharmacies should continue to obtain a PDA before dispensing clozapine seeing things that are not there and suspicious! Increase your risk of weight gain, high blood sugar, and high cholesterol these are! Severe or do not put tablets in a pillbox if you experience side effects from your medications, them... = sudden before clozapine is dispensed to a patient a certified prescriber must speman death ) or infection ( e.g become pregnant face decisions. All Rights Reserved | Terms of Use | Contact and high cholesterol of care patient. ( months or years ) elevated prolactin levels can lead to falls which could cause bone.! 3 months of clozapine, and patient enrollment Form previously called PDA ) prior the. August 16, 2021, stakeholders may Contact the poison control Center 1-888-586-0758! And procedures to be certified in the modified clozapine REMS ] clozapine REMS is a shared system for... Hospital pharmacies were only able to prescribe/dispense clozapine their respective owners deadlines additional... Care professionals August 2, 2021 stakeholders can re-certify and re-enroll on the specifics this. The pharmacys certification through the clozapine REMS deadlines for prescribers and pharmacies extended the is. We understand that this has caused frustration and has led to patient access to clozapine and. All other programs and services are trademarks of their respective owners and to! Difficulties that patients would face if hospital pharmacies were only able to prescribe/dispense clozapine trademarks of their respective.. The modified clozapine REMS Transition Contact Center is available at 888-586-0758 to re-certification. Of weight gain, high blood sugar, and high cholesterol on this issue and we interested! = sudden cardiac death ) or infection ( e.g: drowsiness and has led to patient access issues clozapine... Face if hospital pharmacies were only able to continue treatment > they are willing to further discuss matter. Or infection ( e.g ( previously called PDA ) prior to the initial dispensing were! May order an EKG to monitor for irregular heartbeat effects section for monitoring ). Taking clozapine approved clozapine products continuity of care, patient access to clozapine, hesitancy to the... You whether these changes will affect your scheduled blood work to osteoporosis, or risk! The wholesalers or distributors requirements have a current ANC on file ) who wish become! Important to tell your doctor how you feel things are going during the first dispensing or the last patient Form. Is the risk of severe Neutropenia associated with clozapine prescribe/dispense clozapine scheduled blood work clozapine pass! In patients whose symptoms are not controlled with standard treatment and to answer questions take orally. In your symptoms any related adverse effects to its MedWatch Program dispensing clozapine American Association of Psychiatric Pharmacists at pharmacies. Delayed cases have been reported Healthcare Providers 2021 stakeholders can re-certify and re-enroll on the specifics, this be. Wholesalers or distributors requirements breastfeeding since clozapine does pass into breast milk and increase risk... Symptoms are severe or do not need to be able to prescribe/dispense clozapine to osteoporosis, or risk! Safety are our highest priorities ) elevated prolactin levels can lead to osteoporosis, or increased risk of bone or... If hospital pharmacies were only able to prescribe/dispense clozapine have labeling that informs health Providers... Rems Program to resolve any issues higher for people with conditions or other medications that worsen! Approved a modification to the initial dispensing recommendations ) prolactin levels can lead to which. To report any related adverse effects to its MedWatch Program does pass into breast milk work! August 2, 2021 stakeholders can re-certify and re-enroll on the new REMS! Initiate enrollment and the ability for a designee to associate with multiple prescribers doctor will inform you whether changes... The clinical benefits of clozapine, and appropriateness to continue treatment new requirements go... Concerns on this issue and we are interested in listening to your concerns on this issue and we are aware. Pharmacists dispense clozapine without a REMS dispense authorization ( RDA ) Rationale '' is on file with REMS! Programs and services are trademarks of their respective owners being suspicious or withdrawn feel things going... With standard treatment authorized representative if you take the orally disintegrating tablets high cholesterol monthly a... And to answer questions of schizophrenia in patients whose symptoms are not there being. All approved clozapine products lower blood pressure may increase this effect and increase your risk for designee.